British said rosiglitazone should be withdrawn; Europeans discuss | theheart.org

Links shared publicly online about this topic.

888
total visits

British said rosiglitazone should be withdrawn; Europeans discuss | theheart.org

It has emerged this week that UK experts recommended the withdrawal of the diabetes drug rosiglitazone from the British market in July, although this recommendation was not made public at the time. However, because the drug was approved centrally by the European Medicines Agency, only it can revoke the license, says the UK regulatory body; the EMA is discussing rosiglitazone today, although no final decision is expected on the product until the end of this month.

View full resource at theheart.org

Tags: Heart, Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Drug, Avandia, Avandamet, Avandaryl